Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia - Schlenk, Richard Friedrich; Weber, D.; Krzykalla, J.; Kindler, T.; Wulf, G.; Hertenstein, B.; Salih, H. R.; Südhoff, T.; Krauter, J.; Martens, U.; Wessendorf, S.; Runde, V.; et al. (Scientific reports, 2023)
Online veröffentlicht: 08. September 2023